基于MRI的机器学习预测直肠癌新辅助放化疗后病理完全缓解的系统综述与Meta分析
该系统综述与Meta分析纳入24项研究共1699例直肠癌患者,评估机器学习模型基于MRI预测新辅助放化疗后病理完全缓解的性能。汇总AUC为0.91(95%CI 0.88-0.93),敏感度0.83(95%CI 0.74-0.89),特异度0.86(95%CI 0.80-0.91)。深度学习模型汇总AUC为0.93,传统统计模型为0.89;使用DWI的研究汇总AUC为0.90,未使用DWI为0.92;中国研究汇总AUC为0.93,其他国家为0.83。
要点
- 机器学习模型基于MRI预测直肠癌新辅助放化疗后pCR的汇总AUC为0.91,敏感度0.83,特异度0.86。
- 深度学习模型汇总AUC为0.93,高于传统统计模型的0.89。
- 使用DWI的研究汇总AUC为0.90,未使用DWI的研究为0.92;中国研究为0.93,其他国家为0.83。
核心结论
- 机器学习在预测局部晚期直肠癌患者新辅助放化疗后pCR方面具有前景;深度学习研究虽较少且异质性更大,但可获得更高AUC;结合临床信息,基于机器学习的模型可能使精准医学更近一步。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、Embase、Cochrane Library和Web of Science截至2024年3月前发表的研究,纳入24项研究共1699例患者,采用QUADAS-2评估方法学质量,随机效应模型计算敏感度和特异度,I2值衡量异质性,并进行亚组分析。
诊断标准与关键数值
- 机器学习模型预测pCR的汇总AUC为0.91(95%CI 0.88-0.93),汇总敏感度为0.83(95%CI 0.74-0.89),汇总特异度为0.86(95%CI 0.80-0.91);深度学习模型汇总AUC为0.93,传统统计模型为0.89;使用DWI的研究汇总AUC为0.90,未使用DWI为0.92;中国研究汇总AUC为0.93,其他国家为0.83。
临床应用与阅片要点
- 原文结论指出机器学习在预测pCR方面具有前景,深度学习模型可获得更高AUC,结合临床信息可能使精准医学更近一步。
局限性
- 原文报告异质性,并识别出6项主要贡献异质性的研究,排除这6项研究后重新进行Meta分析,异质性显著降低。
- 原文指出深度学习研究较少且异质性更大。
- 原文结论使用「promising potential」和「may bring us closer」,提示为初步前景。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the performance of machine learning models in predicting pathological complete response (pCR) to neoadjuvant chemoradiotherapy (nCRT) in patients with rectal cancer using magnetic resonance imaging.
METHODS: We searched PubMed, Embase, Cochrane Library, and Web of Science for studies published before March 2024. The Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) was used to assess the methodological quality of the included studies, random-effects models were used to calculate sensitivity and specificity, I2 values were used for heterogeneity measurements, and subgroup analyses were carried out to detect potential sources of heterogeneity.
RESULTS: A total of 1699 patients from 24 studies were included. For machine learning models in predicting pCR to nCRT, the meta-analysis calculated a pooled area under the curve (AUC) of 0.91 (95% CI, 0.88-0.93), pooled sensitivity of 0.83 (95% CI, 0.74-0.89), and pooled specificity of 0.86 (95% CI, 0.80-0.91). We investigated 6 studies that mainly contributed to heterogeneity. After performing meta-analysis again excluding these 6 studies, the heterogeneity was significantly reduced. In subgroup analysis, the pooled AUC of the deep-learning model was 0.93 and 0.89 for the traditional statistical model; the pooled AUC of studies that used diffusion-weighted imaging (DWI) was 0.90 and 0.92 in studies that did not use DWI; the pooled AUC of studies conducted in China was 0.93, and was 0.83 in studies conducted in other countries.
CONCLUSIONS: This systematic study showed that machine learning has promising potential in predicting pCR to nCRT in patients with locally advanced rectal cancer. Compared to traditional machine learning models, although deep-learning-based studies are less predominant and more heterogeneous, they are able to obtain higher AUC.
ADVANCES IN KNOWLEDGE: Compared to traditional machine learning models, deep-learning-based studies are able to obtain higher AUC, although they are less predominant and more heterogeneous. Together with clinical information, machine learning-based models may bring us closer towards precision medicine.
引用
- He J, Wang SX, Liu P, et al. Machine learning in predicting pathological complete response to neoadjuvant chemoradiotherapy in rectal cancer using MRI: a systematic review and meta-analysis. Br J Radiol. 2024. PMID: 38730550. doi:10.1093/bjr/tqae098
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。